Biocryst Pharmaceuticals Inc (BCRX)

EBITDA Margin

45.22%

Quarterly · Period ending:

BCRX logo

BCRX EBITDA Margin

Latest reported45.22%
BCRX Quarterly EBITDA Margin (-1300.00% → 45.22%)
High-resolution chart · PNG

BCRX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
45.2192%
-447.5127%
65.476%
20.155%
17.3838%
16.8916%
-0.9374%
9.9859%
11.4797%
-10.9982%
-40.8518%
-9.285%
-54.8714%
-36.1467%
-56.0827%
-20.8817%
-51.3429%
-99.6795%
7.2628%
-108.4476%
-59.0564%
-268.65%
-1,362.1514%
-699.9181%
-1,236.7119%
-711.8806%
1.6362%
-1,936.1127%
-2,376.5884%
-478.2062%
-909.4907%
-1,860.7978%
-128.5417%
-587.7767%
-440.3599%
-146.3014%
-471.7651%
-126.5974%
-24.4907%
-127.3734%
-308.5649%
-394.2116%
-369.9696%
-119.7961%
20.8614%
-202.2268%
-189.4602%
-230.8215%
-912.6876%
-255.6969%
-39.0839%
-287.1913%
-1,330.2071%
-90.8554%
-177.2495%
-136.7818%
-260.3088%
-38.6548%
-1,224.464%
-240.4267%
-375.4485%
-207.4333%
-54.7332%
-89.0167%
-130.4097%
-8.9678%
28.2015%
-97.6773%
-173.9294%
-205.9417%
29.9862%
-103.0582%
-488.7552%
-126.7088%
-9.9757%
-56.6144%
-54.582%
-7.7498%
-502.387%
-910.0559%
-693.0039%
-1,110.5058%
-34,888.8963%
-24,096.875%
-9,853.4483%
-13,673.1707%
1,719.5513%
-1,930%
-2,298.6175%
-2,982.8729%
-358.2339%
-1,420.7207%
-1,112.0301%
-806.4935%
-670.0668%
-753.6408%
-1,063.9913%
-988.6827%
-67.3874%
4.2941%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.